One of my patients: “Doc, I do not like the name #HeartFailure” Me: “I know” Patient: “You gotta use a different name, Doc” Me: 🤔 #HeartSuccess #PatientVoice

A pleasure to spend an evening with these incredible #WomenInCardiology to inspire and empower the next generation of #WIC @KingsCollegeLon. Thank you @kcl_cardiosoc @kclwim @kclcardiothoracic societies for the invitation & great discussion.We look forward to seeing you all rise!

Tips for differentiating physiology vs. pathological heart the #grayzone #Athleteheart #AHA24

Pearls from Meagan Wasfy, MD ok understanding #Athleteheart #AHA24

Nice summary of the 2024 #HCM guidelines by Hima Viduala, MD #AHA24

And hot off the press #AHA24 LBCT @NEJM simpub phase 1 CRISPR-Cas9 Gene Editing for #ATTRCardiacAmyloidosis trial showed substantial and sustained reduction in the serum TTR level by approximately 90% up to 12 months.

Treatment of #CardiacAmyloidosis #AHA24

A primer on #CardiacAmyloidosis #AHA24 BY Janell Grazzini Frantz, APRN, CNP

✅Emphasis on high arrhythmia risk ✅Progression to end stage HF occurred in 9% ✅clinical trials are needed to guide treatment #AHA24 #CardiacSarcoidosis

Unraveling the mysteries of Sarcoidosis: Dr. Junkka Lehtonen shares the Finnish experience #AHA24 #CardiacSarcoidosis

🫀No info on patients' CV risk prior to pregnancy ie CARPREG II score (cardiac disease in pregnancy risk index) Read More: https://t.co/nkXMBTSJ3n #AHAJournals @iamritu @bnallamo @AHAScience @HeartDocSadiya @DrLaPrincess @SelmaFMohammed @AmberJohnsonMD @KBreathettMD

🫀Unable to account for patients' SE status, as DUA allows researchers to either use date of death or other SE status variables but not both together. 🫀Results may vary for uninsured or underinsured

🫀Data limited by Optum’s proprietary non validated algorithm that classifies race & ethnicity as geospatial variables and name: potential misclassification of Blacks as White patients, underestimation of outcomes for Blacks

Sim Pub with #AHA24 in @CircOutcomes: 🫀In Pre/E Blacks⬆️MACE rates than Whites & > 50% of MACE happens 2 wks after delivery 🫀pre-delivery cardiology care ⬇️MACE by 69% for Whites but not Blacks 🧵 (1/4)

Labor & delivery is one of the highest risk periods for pregnant individuals with CVD. With @ACCinTouch CVD in Women Committee, we put together a practical guide to managing L&D in this high-risk group! Now out in @JACCJournals Advances: https://t.co/4yUY2TahA9

Study findings suggest that race and gender are significantly associated with the probability of donor heart acceptance and that investigation is needed to change modifiable factors contributing to these disparities. https://t.co/U3j7uiDNGn

Why are Black patients more likely to die waiting for a #HeartTransplant? What happens AFTER a patient gets listed for a 💗? 👇🏾 our paper in @JAMA_current (Corrected link 😊 Below) https://t.co/mZ43wmnZ0e

Thanks for reading. Don't lose despair. Progress is attainable through #policy changes, #research, and #implementation Stay tuned for data from my ongoing study to make allocation of 💗and #VAD therapies more equitable, SOCIAL HF study

Check out the thoughtful editorial by @paheidenreich @EldrinL @KiranKhush1 https://t.co/eyHyG3F0BX

What now? @UNOSNews is changing the algorithm to make matching more equitable and systematic. But what about after the match? ⚫️#research and #implementationScience for equitable decision-making ⚫️ address potential bias and structural racism ⚫️ incentivize equity

Adjusting for all the factors, the ODDS of offer acceptance by the transplant team was lower for Black patients through the 16th offer and higher for women through the 6th offer. https://t.co/mZ43wmnZ0e